Prophylaxis of oxidative DNA damage by formamidopyrimidine-DNA glycosylase

International Journal of Cancer

Volumn 119, Issue 1, 2006, Pages 1-7

  Frosina, Guido ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

8 oxoguanine; DNA base excision repair; Gene therapy; Glycosylase; Lung cancer; Mutation; Oxidative DNA damage

Indexed keywords

6 O BENZYLGUANINE; 8 HYDROXYDEOXYGUANOSINE; 8 HYDROXYGUANINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOVIRUS VECTOR; AFLATOXIN B1; ALKYLATING AGENT; AZIRIDINE; BLEOMYCIN; CARMUSTINE; CYCLOBUTANE; DEOXYRIBODIPYRIMIDINE PHOTOLYASE; DIHYDROURACIL; DNA; DNA FORMAMIDOPYRIMIDINE GLYCOSYLASE; ENDONUCLEASE; HYDROGEN PEROXIDE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; OXAZOLONE; PARVOVIRUS VECTOR; PHOSPHORAMIDE MUSTARD; POTASSIUM BROMATE; PYRIMIDINE; REACTIVE OXYGEN METABOLITE; RETROVIRUS VECTOR; THIOTEPA;

ANIMAL CELL; BACTERIAL GENE; CARCINOGENICITY; CELL STRAIN V 79; CHO CELL; CONTROLLED STUDY; DNA DAMAGE; EXCISION REPAIR; GAMMA IRRADIATION; GENE; GENE THERAPY; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENOMIC INSTABILITY; GENOTOXICITY; HERPES SIMPLEX VIRUS 1; HETEROLOGOUS EXPRESSION; HOGG1 GENE; INFLAMMATION; INTERNAL RIBOSOME ENTRY SITE; LUNG ALVEOLUS EPITHELIUM; LUNG CANCER; MUTAGENICITY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NTH GENE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; SHORT SURVEY; SMOKING;

ADENOVIRIDAE; ANIMALS; CELL CULTURE TECHNIQUES; DEPENDOVIRUS; DNA DAMAGE; DNA GLYCOSYLASES; DNA REPAIR; DNA-FORMAMIDOPYRIMIDINE GLYCOSYLASE; ESCHERICHIA COLI PROTEINS; GENETIC VECTORS; HUMANS; LUNG; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RESPIRATORY MUCOSA; RETROVIRIDAE; SMOKING;

EID: 33646508777     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21793     Document Type: Short Survey

References (50)

1. Speina E, Zielinska M, Barbin A, Gackowski D, Kowalewski J, Graziewicz MA, Siedlecki JA, Olinski R, Tudek B. Decreased repair activities of 1,N(6)-ethenoadenine and 3,N(4)-ethenocytosine in lung adenocarcinoma patients. Cancer Res 2003;63:4351-57.
2. Daniels CE, Jett JR. Does interstitial lung disease predispose to lung cancer? Curr Opin Pulm Med 2005;11:431-7.
3. Bames D, Lindahl T. Repair and genetic consequences of endogenous DNA base damage in mammalian cells. Annu Rev Genet 2004;38:445-76.
4. Reardon JT, Bessho T, Kung HC, Bolton PH, Sancar A. In vitro repair of oxidative DNA damage by human nucleotide excision repair system: possible explanation for neurodegeneration in xeroderma pigmentosum patients. Proc Natl Acad Sci USA 1997;94:9463-8.
5. Huang MF, Kolodner RD. A biological network in Saccharomyces cerevisiae prevents the deleterious effects of endogenous oxidative DNA damage. Mol Cell 2005;17:709-20.
6. Ishibashi T, Hayakawa H, Sekiguchi M. A novel mechanism for preventing mutations caused by oxidation of guanine nucleotides. EMBO Rep 2003;4:479-83.
7. Jaruga P, Dizdaroglu M. Repair of products of oxidative DNA base damage in human cells. Nucleic Acids Res 1996;24:1389-94.
8. Cappelli E, Degan P, Frosina G. Comparative repair of the endogenous lesions 8-oxoguanine, uracil and abasic site by mammalian cell extracts: 8-oxoguanine is poorly repaired by human cell extracts. Carcinogenesis 2000;21:1135-41.
9. Asagoshi K, Yamada T, Terato H, Ohyama Y, Monden Y, Arai T, Nishimura S, Aburatani H, Lindahl T, Ide H. Distinct repair activities of human 7,8-dihydro-8-oxoguanine DNA glycosylase and formamidopyrimidine DNA glycosylase for formamidopyrimidine and 7,8-dihydro-8-oxoguanine. J Biol Chem 2000;275:4956-64.
10. Coste F, Ober M, Carell T, Boiteux S, Zelwer C, Castaing B. Structural basis for the recognition of the FapydG lesion (2,6-diamino-4-hydroxy-5- formamidopyrimidine) by formamidopyrimidine-DNA glycosylase. J. Biol. Chem. 2004;279:44074-83.
11. Cappelli E, Hazra T, Hill JW, Slupphaug G, Bogliolo M, Frosina G. Rates of base excision repair are not solely dependent on levels of initiating enzymes. Carcinogenesis 2001;22:387-93.
12. Vidal AE, Hickson ID, Boiteux S, Radicella JP. Mechanism of stimulation of the DNA glycosylase activity of hOGG1 by the major human AP endonuclease: bypass of the AP lyase activity step. Nucleic Acids Res 2001;29:1285-92.
13. Morland I, Luna L, Gustad E, Seeberg E, Bjoras M. Product inhibition and magnesium modulate the dual reaction mode of hOGG1. DNA Repair 2005;4:381-7.
14. Gilboa R, Zharkov DO, Golan G, Fernandes AS, Gerchman SE, Matz E, Kycia JH, Grollman AP, Shoham G. Structure of formamidopyrimidine-DNA glycosylase covalently complexed to DNA. J Biol Chem 2002;277:19811-16.
15. Jurado J. Saparbaev M, Matray TJ, Greenberg MM, Laval. J. The ring fragmentation product of thymidine C5-hydrate when present in DNA is repaired by the Escherichia coli Fpg and Nth proteins. Biochemistry 1998;37:7757-63.
16. Zaika EI, Perlow RA, Matz E, Broyde S, Gilboa R, Grollman AP, Zharkov DO. Substrate discrimination by formamidopyrimidine-DNA glycosylase-a mutational analysis. J Biol Chem 2004;279:4849-61.
17. Wu M. DNA repair proteins as molecular therapeutics for oxidative and alkylating lung injury. Curr Gene Ther 2005;5:225-36.
18. Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation and disease. FASEB J 2003;17:1195-1214.
19. Frosina G. DNA base excision repair defects in human pathologies. Free Radic Res 2004;38:1037-54.
20. Asami S, Manabe H, Mijake J, Tsurudome Y, Hirano T, Yamaguchi R, Itoh H, Kasai H. Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxyguanosine, in a central site of the human lung. Carcinogenesis 1997;18:1763-6.
21. Paz-Elizur T, Krupsky M, Blumenstein S, Elinger D, Schectman E, Livneh Z. DNA repair activity for oxidative damage and risk of lung cancer. J NCI 2003;95:1312-19.
22. Weiss JM, Goode EL, Ladiges WC, Ulrich CM. Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. Mol Carcinog 2005;42:127-41.
23. Klungland A, Rosewell I, Hollenbach S, Larsen E, Daly G, Epe B, Seeberg E, Lindahl T, Barnes DE. Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc Natl Acad Sci USA 1999;96:13300-5.
24. Epe B. Role of endogenous oxidative DNA damage in carcinogenesis: what can we learn from repair-deficient mice? Biol Chem 2002;383:467-75.
25. Xie Y, Yang H, Cunanan C, Okamoto K, Shibata D, Pan J, Barnes DE, Lindahl T, McIlhatton M, Fishel R, Miller JH. Deficiencies in mouse Myh and Ogg1 result in tumor predisposition and G to T mutations in codon 12 of the K-Ras oncogene in lung tumors. Cancer Res 2004;64:3096-102.
26. Russo MT, De Luca G, Degan P, Parlanti E, Dogliotti E, Barnes DE, Lindahl T, Yang H, Miller JH, Bignami M. Accumulation of the oxidative base lesion 8-hydroxyguanine in DNA of tumor-prone mice defective in both the MYH and OGG1 DNA glycosylases. Cancer Res 2004;64:4411-14.
27. Frosina G. Overexpression of enzymes that repair endogenous damage to DNA. Eur. J. Biochem. 2000;267:2135-2149.
28. Harrison I, Skorvaga M, Cunningham RP, Hendry JH, Margison GP. Transfection of the Escherichia coli nth gene into radiosensitive Chinese hamster cells: effects on sensitivity to radiation, hydrogen peroxide, and bleomycin sulfate. Radiat Res 1992;132:30-9.
29. Wu M, He YH, Kobune M, Xu Y, Kelley MR, Martin WJ. 2nd Protection of human lung cells against hyperoxia using the DNA base excision repair genes hOGG1 and Fpg. Am J Respir Crit Care Med 2002;166:192-9.
30. He Y-H, Xu Y, Kobune M, Wu M, Kelley MR, Martin WJ, II. Escherichia coli FPG and human OGG1 reduce DNA damage and cytotoxicity by BCNU in human lung cells. Am J Physiol Lung Cell Mol Physiol 2002;282:L50-5.
31. Hollenbach S, Dhenaut A, Eckert I, Radicella JP, Epe B. Overexpression of Ogg1 in mammalian cells: effects on induced and spontaneous oxidative DNA damage and mutagenesis. Carcinogenesis 1999;20:1863-8.
32. Prieto-Alamo MJ, Laval F. Overexpression of the human HAP1 protein sensitizes cells to the lethal effect of bioreductive drugs. Carcinogenesis 1999;20:415-19.
33. Sossou M, Flohr-Beckhaus C, Schulz I, Daboussi F, Epe B, Radicella JP. APE1 over expression in XRCC1-deficient cells complements the defective repair of oxidative single strand breaks but increases genomic instability. Nucleic Acids Res 2005;33:298-306.
34. Robertson KA, Bullock HA, Xu Y, Tritt R, Zimmermann E, Ulbright TM, Foster RS, Einhorn LH, Kelley MR. Altered expression of Ape/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. Cancer Res 2001;61:2220-5.
35. Rinne M, Caldwell D, Kelley MR. Transient adenoviral N-ethylpurine DNA glycosylase overexpression imparts chemotherapeutic sensitivity to human breast cancer cells. Mol Cancer Ther 2004;3:955-67.
36. Laval F. Expression of the E. coli fpg gene in mammalian cells reduces the mutagenicity of γ-rays. Nucleic Acids Res 1994;22:4943-6.
37. Cussac C, Laval F. Reduction of the toxicity and mutagenicity of aziridine in mammalian cells harboring the Escherichia coli fpg gene. Nucleic Acids Res 1996;24:1742-6.
38. Gill RD, Cussac C, Souhami RL, Laval F. Increased resistance to N,N′,N′;-triethylenethiophosphoramide (thioTEPA) in cells expressing the Escherichia coli formamidopyrimidine-DNA glycosylase. Cancer Res 1996;56:3721-4.
39. Kobune M, Xu Y, Baum C, Kelley MR, Williams DA. Retrovirus-mediated expression of the base excision repair proteins, formamidopyrimidine DNA glycosylase or human oxoguanine DNA glycosylase, protects hematopoietic cells from N,N′,N″-triethylenethiophosphoramide (thioTEPA)-induced toxicity in vitro and in vivo. Cancer Res 2001;61:5116-25.
40. Ropolo M, Geroldi A, Degan P, Andreotti V, Zupo S, Poggi A, Reed A, Kelley MR, Frosina G. Accelerated repair and reduced mutagenicity of oxidative DNA damage in human bladder cells expressing the E. coli FPG protein. Int J Cancer, in press.
41. Schul W, Jans J, Rijksen YM, Klemann KH, Eker AP, de Wit J, Nikaido O, Nakajima S, Yasui A, Hoeijmakers JH, van der Horst GT. Enhanced repair of cyclobutane pyrimidine dimers and improved UV resistance in photolyase transgenic mice. EMBO J 2002;21:4719-29.
42. Neff T, Horn PA, Peterson LJ, Thomasson BM, Thompson J, Williams DA, Schmidt M, Georges GE, von Kalle C, Kiem H-P. Methylguanine methyltransferase- mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model. J Clin Invest 2003;112:1581-8.
43. Galimi F, Noll M, Kanazawa Y, Lax T, Chen C, Grompe M, Verma IM. Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors. Blood 2002;100:2732-6.
44. Marchetto MC, Muotri AR, Burns DK, Friedberg EC, Menck CF. Gene transduction in skin cells: preventing cancer in xeroderma pigmentosum mice. Proc Natl Acad Sci USA 2004;101:17759-64.
45. Jans J, Schul W, Sert YG, Rijksen Y, Rebel H, Eker AP, Nakajima S, van Steeg H, de Gruijl FR, Yasui A, Hoeijmakers JH, van der Horst GT. Powerful skin cancer protection by a CPD-photolyase transgene. Curr Biol 2005;15:105-15.
46. Arnaudeau-Begard C, Brellier F, Chevallier-Lagente O, Hoeijmakers J, Bernerd F, Sarasin A, Magnaldo T. Genetic correction of DNA repair-deficient/ cancer-prone xeroderma pigmentosum group C keratinocytes. Hum Gene Ther 2003;14:983-96.
47. Jackson EL, Jacks T, MMHCC Lung Cancer Organ Site. Available at http://emice.nci.nih.gov/emice/mouse_models/organ_models/lung_ models/murinecancer/murinemodels#table.
48. Zhou NY, Bates SE, Bouziane M, Stary A, Sarasin A, O'Connor TR. Efficient repair of cyclobutane pyrimidine dimers at mutational hot spots is restored in complemented xeroderma pigmentosum group C and trichothiodystrophy/xeroderma pigmentosum group D cells. J Mol Biol 2003;332:337-51.
49. Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003;348:255.
50. Urnov FD, Miller JC, Lee YL, Beausejour CM, Rock JM, Augustus S, Jamieson AC, Porteus MH, Gregory PD, Holmes MC. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 2005;435:646-51.